- Janus Kinase Inhibitors in the Treatment of Alopecia Areata2023 | Third Faculty of Medicine
- Efficacy of Janus kinase inhibitors on skin syndrome in patients with psoritic arthritis2022 | First Faculty of Medicine
- Janus kinase inhibitors in clinical practice: data from the ATTRA registry2020 | First Faculty of Medicine
- Clinical experience with Janus kinase inhibitors2019 | First Faculty of Medicine
- Inhibitors of Janus kinases in the therapy of rheumatoid arthritis2019 | First Faculty of Medicine
- Janus kinase inhibitors in the treatment of rheumatoid arthritis2020 | First Faculty of Medicine
- The role od Janus kinase inhibitors in the therapy of psoriatic arthritis2023 | First Faculty of Medicine
- Abrocitinib2022 | Faculty of Medicine in Pilsen
- Expanding possibilities of rheumatoid arthritis and spondyloarthritis treatment2018 | Faculty of Medicine in Hradec Králové
- Alopecia areata - basic disease characteristics and an overview of current and new treatment options2022 | Third Faculty of Medicine
- Utility of Ruxolitinib in a Child with Chronic Mucocutaneous Candidiasis Caused by a Novel STAT1 Gain-of-Function Mutation2018 | First Faculty of Medicine, Second Faculty of Medicine
- Baricitinib in treating rheumatoid arthritis2018 | First Faculty of Medicine
- Influence of In Vitro IL-2 or IL-15 Alone or in Combination with Hsp-70-Derived 14-mer Peptide (TKD) on the Expression of NK Cell Activatory and Inhibitory Receptors2013 | Third Faculty of Medicine
- Severe form of atopic dermatitis - Successful treatment with abrocitinib2023 | Third Faculty of Medicine
- The PD-L1-Associated Carcinogenesis May Encompass Oncogenes UHRF2 and PTPRDPublication without faculty affiliation
- JAK inhibition in the treatment of inflammatory rheumatic diseases2023 | First Faculty of Medicine
- Tofacitinib in treating psoriatic arthritis2019 | First Faculty of Medicine
- Vaccination of the patients with autoimmune inflammatory disease on treatment with new biologics and JAK inhibitors2019 | First Faculty of Medicine
- Safety of filgotinib tratment2023 | First Faculty of Medicine
- Possibilities for monotherapy with tofacitinib in clinical practice2018 | First Faculty of Medicine
- ASAS‑EULAR recommendations for the treatment of axial spondylarthritis: an update2023 | First Faculty of Medicine
- Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe2023 | First Faculty of Medicine
- Selected case reports from the tofacitinib clinical program2019 | First Faculty of Medicine
- Deoxynivalenol: signaling pathways and human exposure risk assessment-an update2014 | Publication without faculty affiliation
- Cancer prevention and therapy through the modulation of the tumor microenvironment2015 | Third Faculty of Medicine
- Apoptosis and eryptosis: similarities and differences2023 | First Faculty of Medicine
- Dimethyl fumarate induces ferroptosis and impairs NF-kappa B/STAT3 signaling in DLBCL2021 | First Faculty of Medicine
- Treatment of polycythemia vera2018 | Faculty of Medicine in Hradec Králové
- Preformed STAT3 transducer complexes in human HepG2 cells and rat hepatocytes2007 | Third Faculty of Medicine
- Coexistence of gain-of-function JAK2 germ line mutations with JAK2V617F in polycythemia vera2016 | Faculty of Science